Delivery Order SPE2DB20D3104-SPE2DB25FW0A4
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,075.75 to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 110 micrograms in 12-gram inhalers. This non-set-aside contract was awarded on August 5, 2025, with an ultimate completion date of August 6, 2025, and operates under firm fixed price terms. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,498.25 to AmerisourceBergen Drug Corp for the supply of Fluticasone Propionate HFA 110 micrograms in a 12-gram inhaler. This firm fixed price contract, issued on July 28, 2025, with an ultimate completion date of July 29, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The order...
- The Defense Logistics Agency awarded a delivery order valued at $2,436.13 to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 110 micrograms in 12-gram inhalers. This contract, issued on August 25, 2025, with completion scheduled for August 26, 2025, utilizes firm fixed pricing and represents a non-set-aside competitive award. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's corporate headquarters and primary distribution center...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Fluticasone Propionate HFA 110 micrograms in 12-gram inhalers, with a contract value of $24,494.88 and an ultimate completion date of July 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued as a competitive award under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive...
- The Defense Logistics Agency awarded a delivery order valued at $3,192.98 to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Fluticasone Propionate HFA 44 micrograms in 10.6-gram inhalers. This was a competitively awarded, firm fixed-price delivery order with no set-aside designation, with an ultimate completion date of August 26, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $1,340.27 to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 44 micrograms in a 10.6-gram inhaler, with an ultimate completion date of August 11, 2025. This non-competitive, firm fixed-price delivery order was issued on August 8, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 44 mcg inhalers (10.6 gm) valued at $2,799.78 on August 27, 2025, with an ultimate completion date of August 28, 2025. This firm fixed-price delivery order carries no set-aside designation and represents a competitive award under the company's existing contract vehicle with DLA. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $11,271.90 to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Fluticasone Propionate HFA 110 micrograms in 12-gram inhalers. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award, and is scheduled for completion by August 25, 2025. Performance will be executed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,715.83 on July 29, 2025, for the supply of Fluticasone Propionate HFA 44 microgram inhalers (10.6 grams). This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical supply vehicle running through December 2026. The product will be...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 44 micrograms in a 10.6-gram inhaler, with a ceiling value of $1,045.92. The contract was competitively awarded without a set-aside designation and carries a firm fixed price structure with a completion date of August 21, 2025. This delivery order is performed out of the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- SPE2DB20D3104Indefinite Delivery Contract
- SPE2DB20D3104-SPE2DB25FW0A4Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,058.92 to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 110 micrograms in 12-gram inhalers. This competitive award, issued on September 8, 2025, with an ultimate completion date of September 9, 2025, represents a firm fixed-price transaction with no set-aside designation. The place of performance is located at the awardee's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and running through December 2026. AmerisourceBergen Drug Corp serves as a prime vendor for the Defense Logistics Agency's Medical Supply Chain, supplying a broad portfolio of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The company's federal contract portfolio demonstrates consistent capability to fulfill competitive federal medical procurement requirements across multiple therapeutic domains, including respiratory treatments such as this fluticasone order, supporting the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 9/8/25 |